Trial intelligence / Profile preview

Recombinant Growth Hormone in Children Born Small for Gestational Age Without Catch-up Growth

2005-001507-19Phase 4Completed

Sponsor
National Children's Hospital
Start
Apr 2005
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, single-arm trial of somatropin in growth disorder and Small for gestational age (SGA), sponsored by National Children's Hospital. Primary endpoint: Height gain (3-year ΔSDS). Started Apr 2005; status: completed.

02

Drugs

somatropin
03

Conditions

growth disorderSmall for gestational age (SGA)

Beyond the preview

Go deeper on 2005-001507-19.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-001507-19.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call